How Analysts Feel About Aurora Cannabis Inc. (ACB) After Today’s Significant Increase?

The stock of Aurora Cannabis Inc. (NYSE:ACB) is a huge mover today! The stock increased 12.94% or $1.03 during the last trading session, reaching …

The stock of Aurora Cannabis Inc. (NYSE:ACB) is a huge mover today! The stock increased 12.94% or $1.03 during the last trading session, reaching $8.99. About 111.17 million shares traded or 378.38% up from the average. Aurora Cannabis Inc. (NYSE:ACB) has declined 10.79% since March 13, 2018 and is downtrending. It has underperformed by 15.16% the S&P500.

The move comes after 7 months positive chart setup for the $9.27 billion company. It was reported on Mar, 13 by We have $9.35 PT which if reached, will make NYSE:ACB worth $370.72M more.

Analysts await Aurora Cannabis Inc. (NYSE:ACB) to report earnings on May, 14. They expect $-0.05 EPS, down 25.00 % or $0.01 from last year’s $-0.04 per share. After $-0.04 actual EPS reported by Aurora Cannabis Inc. for the previous quarter, Wall Street now forecasts 25.00 % negative EPS growth.

More notable recent Aurora Cannabis Inc. (NYSE:ACB) news were published by: which released: “Aurora Cannabis Just Hit a Dubious Milestone – Motley Fool” on March 11, 2019, also with their article: “Cronos leading pot stock rally – Seeking Alpha” published on February 04, 2019, published: “Aurora Cannabis (NYSE:ACB) Appoints Nelson Peltz As Strategic Advisor: ‘Solid Execution, Strongly Differentiated From Its Peers’ – Benzinga” on March 13, 2019. More interesting news about Aurora Cannabis Inc. (NYSE:ACB) were released by: and their article: “Tilray Leapfrogs Aurora Cannabis and Canopy Growth in the U.S. Hemp Market – The Motley Fool” published on February 20, 2019 as well as‘s news article titled: “Why There Are At Least 2 Monster Years Ahead For Aurora Cannabis – Seeking Alpha” with publication date: February 01, 2019.

Aurora Cannabis Inc. produces and distributes medical cannabis products. The company has market cap of $9.27 billion. It is vertically integrated and horizontally diversified across various divisions of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. It has a 41.62 P/E ratio. The company’s products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

CBD Hacker Ranks the 20 Best CBD Oil Drops for 2019 [With Lab Results]

CBD Hacker’s team incorporated third-party lab analysis, hands-on evaluation, and company research to narrow down a list of dozens of brands and …
Photo of bottles of the top five CBD oils from CBD Hacker's 2019 CBD oil ranking

CBD Hacker ranks the 20 Best CBD Oil Drops for 2019

The most competitive CBD brands are working hard to demonstrate their quality and dependability.

BOARDMAN, Ohio (PRWEB)March 13, 2019

CBD Hacker, the definitive guide to the CBD industry, has updated their ranking of the top CBD oil brands with their revised and expanded list of the 20 Best CBD Oil Drops for 2019.

Each product received a score for five categories:

  • Product quality and value
  • User experience
  • Customer service
  • Reputation
  • Transparency and labeling accuracy

What’s new in this year’s updated ranking?

In the last year, many of the leading CBD brands have made significant changes. From taking control of the supply chain by growing their own hemp, to adopting more consumer-friendly guarantees and transparency practices, the trends reveal an industry that is vying to gain consumer confidence.

“In the CBD industry right now, it’s all about trust,” said Meg Kramer, CBD Hacker’s managing editor. “An increase in media coverage is increasing awareness about CBD. At the same time, it’s helping consumers to be more savvy about the potential risks in buying unregulated products. That means that the most competitive brands are working hard to demonstrate their quality and dependability.”

CBD Hacker’s team cast a wide net for this ranking, starting with a list of over 60 brands, and more than 30 products made it through the gantlet to be considered for the final list. The full ranking includes the following CBD companies:

  • 4 Corners Cannabis – Bayfield, Colorado
  • Bluebird Botanicals – Louisville, Colorado
  • CBDistillery – Denver, CO
  • Charlotte’s Web – Denver, CO
  • EsseCann – Valrico, FL
  • Fab – Tampa, FL
  • Green Gorilla – Malibu, CA
  • Head + Heal – Cortland, NY
  • Hoboken Hemp – Hoboken, NJ
  • Joy Organics – Fort Collins, Colorado
  • Lazarus Naturals – Seattle, WA
  • Mission Farms – Bend, OR
  • NuLeaf Naturals – Denver, CO
  • Oilly CBD – Algonquin, IL
  • PlusCBD Oil – San Diego, CA
  • Populum – Tempe, AZ
  • Press Pause Project – Denver, CO
  • Pure Kind Botanicals – Fort Lupton, CO
  • Pure Spectrum – Evergreen, CO
  • RE Botanicals – Denver, CO

In addition, the ranking highlights companies that performed exceptionally well in specific categories, such as the best organic, full-spectrum, and THC-free CBD products.

About CBD Hacker:

CBD Hacker’s mission is to introduce transparency into an unregulated and confusing industry. With cannabidiol’s growing popularity, the CBD industry is experiencing rapid growth—but it has little to no oversight. CBD Hacker uses evidence-based reporting, third-party lab testing and blind product-testing methodology to dispel misinformation and help consumers to know what they are buying.

Related Posts:

  • No Related Posts

Aurora Cannabis’ Is a Beast but the Stock Has Entered a Tricky Area Now

Aurora Cannabis Inc. (ACB) made waves on Wednesday morning when it announced Nelson Peltz as a “strategic advisor.” It’s easy to understand the …

Aurora Cannabis Inc. (ACB) made waves on Wednesday morning when it announced Nelson Peltz as a “strategic advisor.”

It’s easy to understand the excitement behind the move by the Canadian company.

A consummate deal maker, Peltz brings a ton of experience and plenty of contacts. He currently serves as a director for The Procter & Gamble Co. (PG) , Sysco Corp. (SYY) , and The Madison Square Garden Co. (MSG) , plus is the non-exec chairman of The Wendy’s Co. (WEN) .

The potential tie-ins from ANY of these companies with possible future products derived from cannabis is huge. The health and beauty supplement business from the Edmonton-based ACB could be one of the biggest winners over the next decade. It’s possible we’ll see food crossovers as well.

This move has the potential to propel Aurora to the negotiating table in JVs, or could make it an enticing target for one of Peltz’s current or former connections.

In exchange for his role, Peltz received options to purchase 19,961,754 common shares at CAD$10.34, roughly the closing price Tuesday.

Given the move Wednesday, that’s a cool $20 million already.

Still, it’s important to note those shares vest over four years, so it isn’t as if Peltz could exercise and cash in those shares tomorrow.

This does hint at one concern I have about ACB. The company hands out shares like a big-hearted grandma with an unlimited supply of hard candy. After recent transactions settle, ACB is going to have more than a billion shares outstanding. The greater the number of shares, the more difficult it can be to move the needle.

Don’t get me wrong, I like ACB. The company is a beast. There won’t be another producer that will sniff what ACB can produce. While Canopy Growth Corp. (CGC) and Tilray, Inc. (TLRY) continue to steal the headlines, Aurora may actually be top dog.

The shares are breaking out Wednesday with a strong move above recent resistance. The $8.00 – $8.25 area should become new support with $7.50 as secondary support.

A close under $7.50 and I’d be concerned bears were in charge, paving a path to the $6s.

ACB has entered a bit of a vacuum here. Traders from October still holding shares are begging to exit at a break-even or close status. Those buying from November onward are enjoying strong gains, but it is important to note that only buyers of the past six weeks have rarely been down much in the stock. Watching a position drop, even if it recovers, weighs on the psyche of investors.

In short, I don’t expect this to be a clear or easy climb to the $10 area, but I do believe the new trading range for the stock will be $7.50-$10.75, which favors buyers even here. I’m of the notion to see if we consolidate for a few days and look for the opportunity to buy closer to $8. For those that don’t want to wait, ACB has a fantastic options market, and selling out-of-the-money puts month-to-month has been a favorite approach for me.

Overall, despite not loving that more shares are being issued, I find the move to add Peltz a strong one. ACB is pushing the cannabis business hard and fast, but with more experienced names coming into the advisory role, it should emerge as one of the big cannabis winners.

Aurora Cannabis is a holding in TheStreet’s Stocks Under $10 portfolio. Click here to learn more about this portfolio, trading ideas and market commentary product.

Will You Have Enough Money to Retire?

Want to learn about retirement planning from some of the nation’s top experts? Join TheStreet’s Robert “Mr. Retirement” Powell live in New York on April 6 for our Retirement Strategies Symposium. For a limited time, tickets are available for $99 for this full-day event. Check out the agenda, learn about the speakers and sign up here.

Related Posts:

  • No Related Posts

Why Nelson Peltz Is A Good Fit For Aurora Cannabis

Cannabis company Aurora Cannabis Inc (NYSE: ACB) said Wednesday it struck a new relationship with Nelson Peltz. The activist investor will serve …

Cannabis company Aurora Cannabis Inc (NYSE: ACB) said Wednesday it struck a new relationship with Nelson Peltz. The activist investor will serve as a strategic advisor with the aim of helping the company expand globally and better address major cannabis market segments.

What To Know

Peltz is known for his activist investor campaigns, and Aurora Chairman Michael Singer told CNBC he’s “someone who proactively works with companies to maximize value for stakeholders.”

Peltz doesn’t have an “antagonistic approach” toward Aurora and will help the company in potential growth areas, especially consumer packaged goods, Singer said. Peltz brings an “incredible track record of successfully engaging with global companies” to the table, he said.

The Cannabis Capital Conference is coming back to Toronto! Click here to learn how you can join Tim Seymour, Jon Najarian and many others.

Aurora has identified multiple growth areas it should be in a better position to address with the help of Peltz, Singer said. He named the beverage, cosmetics, health and wellness and pharmaceutical segments.

“There are a number of what we call market segments that we expect to operate in with one or many of these potential partners,” Singer said.

Some of the biggest consumer packaged goods companies are now “starting to make a little noise” in the cannabis space, Singer said. Over time, this will shift to “a lot more noise about partnering with companies like Aurora,” he said.

How Peltz Fits In

Peltz’s expertise on pushing companies to focus on profitability and efficient asset allocation will “prove valuable” for Aurora’s next stage of growth, Business Insider quoted Jefferies’ Owen Bennett as saying in a research report.

The activist investor, Bennett said, should be able to help the cannabis company solve its most pressing issue: spending too much capital on too many assets.

“Peltz should support in ensuring assets are kept that yield most value,” Bennett was quoted as saying. “Given his past, we would also suggest that his involvement should support in maximizing the route towards profitability.”

Aurora’s stock traded 12 percent higher to $8.92 per share at time of publication.

Related Links:

Cowen Bullish On Aurora Cannabis, Takes Neutral Stance On Cronos

Jim Cramer Shares His Predictions For The Cannabis Industry

Latest Ratings for ACB

Date Firm Action From To
Mar 2019 Cowen & Co. Initiates Coverage On Outperform
Feb 2019 Jefferies Initiates Coverage On Buy
Feb 2019 Seaport Global Initiates Coverage On Neutral

View More Analyst Ratings for ACB

View the Latest Analyst Ratings

Related Posts:

  • No Related Posts

Aurora Cannabis Spikes After Billionaire Activist Nelson Peltz Added as Adviser

Rival Canopy Growth Corp. (CGC – Get Report) was also on the move following the Peltz addition, with shares rising 1.3% in pre-market trading to …

Aurora Cannabis Inc. (ACB) shares were marked sharply higher Wednesday after it named billionaire activist investor Nelson Peltz as a strategic adviser to the Canada-based group.

Peltz will advise the group on its global acquisition strategy and potential business partnership, Aurora Cannabis said, and will be granted options to purchase around 20% of the company’s shares at C$10.34 each ($7.74).

“Nelson is a globally recognized business visionary with a strong track record of constructive engagement to generate accelerated, profitable growth and shareholder value across many industry verticals that are of great interest to us,” said CEO Terry Booth. “Like us, Nelson also takes a long-term view of value creation to benefit all stakeholders. We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact.”

Aurora Cannabis shares were marked 10.5% higher at the opening bell Wednesday to change hands at $8.81 each, a move that would extend the stock’s year-to-date advance to around 68%.

Rival Canopy Growth Corp. (CGC) was also on the move following the Peltz addition, with shares rising 1.9% to change hands at $47.66 each. Cronos Group Inc. (CRON) , jumped 1.8% $21.75 each.

“I believe Aurora has a solid execution track record, is strongly differentiated from its peers, has achieved integration throughout the value chain and is poised to go to the next level across a range of industry verticals,” Peltz said. “I also believe that Canadian licensed producers, and Aurora in particular, are well positioned to lead in the development of the international cannabis industry as regulations evolve, with a strong, globally replicable operating model.”

Last month, Aurora Cannabis posted a wider-than-expected fiscal second-quarter loss of C$237.8 million but said it sold 6,999 kg of cannabis over the three month period, helping revenues rise to C$54.2 million.

Related Posts:

  • No Related Posts